TET2 and angioimmunoblastic T-cell lymphoma: The frequency of TET2 repression or loss in T-ALL even exceeds the frequency (30% to 65%) of TET2 loss-of-function mutations observed in angioimmunoblastic T-cell lymphoma in adults (58, –60).